Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00102) | |||||
---|---|---|---|---|---|
Name |
Carprofen
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
carprofen; 53716-49-7; 2-(6-Chloro-9H-carbazol-2-yl)propanoic acid; Rimadyl; Imadyl; Ridamyl; Carprofene; Carprofeno; Carprofenum; Carprofene [INN-French]; Carprofenum [INN-Latin]; 6-Chloro-alpha-methyl-9H-carbazole-2-acetic acid; Carprofeno [INN-Spanish]; 6-Chloro-alpha-methylcarbazole-2-acetic acid; Ro 20-5720/000; Carprofen-d3; (+-)-6-Chloro-alpha-methylcarbazole-2-acetic acid; 2-(6-Chloro-9H-carbazol-2-yl)-propionic acid; MFCD00079028; CHEMBL1316; (+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid; CHEBI:364453; NSC297935; NCGC00094937-01; Carprodyl; Carprofeno [Spanish]; Ro-205720000; 2-(6-chloro-9H-carbazol-2-yl)-3,3,3-trideuteriopropanoic acid; DSSTox_CID_25871; DSSTox_RID_81189; DSSTox_GSID_45871; (.+-.)-6-Chloro-.alpha.-methylcarbazole-2-acetic acid; Carpaquin; Norocarp; Ro 20-5720; SMR000718633; Rimadyl (TN); C 5720; CAS-53716-49-7; CCRIS 3507; SR-01000837515; EINECS 258-712-4; NSC 297935; BRN 0487098; Carprofen [USAN:USP:INN:BAN]; PubChem9953; 52263-47-5; Ro-20-5720; Carprofen (USP/INN); Spectrum2_001236; Spectrum3_000939; Spectrum4_001038; Spectrum5_001802; Ro-20-5720/000; SCHEMBL3909; (+-)-6-Chlor-alpha-methyl-2-carbazolessigsaeure; KBioGR_001595; 5-22-03-00391 (Beilstein Handbook Reference); MLS001201778; MLS001306441; SPECTRUM1502006; SPBio_001112; GTPL7141; 9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl-; Carprofen, >=97% (HPLC); DTXSID1045871; KBio3_001978; HMS1921D04; HMS2092B16; HMS2234P15; HMS3652E20; HMS3715F09; HMS3748C07; HMS3885F07; Pharmakon1600-01502006; ACT03356; HY-B1227; Tox21_111363; 9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl-, (.+-.)-; 9H-CARBAZOLE-2-ACETIC ACID, 6-CHLORO-alpha-METHYL-, (+-)-; BBL009935; BDBM50097346; CCG-39146; NSC758154; STK711093; 9H-Carbazole-2-acetic acid, (-)-; AKOS005530663; Tox21_111363_1; AC-1266; CS-4875; DB00821; KS-1163; LS41073; MCULE-9476030813; NE55949; NSC-297935; NSC-758154; NCGC00094937-02; NCGC00094937-04; NCGC00094937-05; 9H-Carbazole-2-acetic acid, (.+-.)-; AK343600; SBI-0052885.P002; AB0012886; FT-0602833; FT-0664393; FT-0664394; FT-0664395; SW199610-3; 6-chloro-alpha-methyl-carbazole-2-acetic acid; Carprofen, VETRANAL(TM), analytical standard; C18364; D03410; J10272; 2-(6-chloranyl-9H-carbazol-2-yl)propanoic acid; AB00876263_06; AB00876263_07; 716C497; A829748; Q905755; (+/-)-6-Chloro-alpha-methylcarbazole-2-aceticacid; SR-01000837515-2; SR-01000837515-3; (+/-)-6-Chloro-alpha-methylcarbazole-2-acetic acid; BRD-A17411484-001-05-1; Z1814381791; 2-(6-Chloro-9H-carbazol-2-yl)-propionic acid(carprofen); Carprofen, European Pharmacopoeia (EP) Reference Standard; 9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl-, (-)-; Carprofen, United States Pharmacopeia (USP) Reference Standard; Carprofen, Pharmaceutical Secondary Standard; Certified Reference Material; Carprofen for system suitability, European Pharmacopoeia (EP) Reference Standard
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Anaesthesia | ICD-11: 8E22 | [1] | ||
PubChem CID | |||||
Formula |
C15H12ClNO2
|
||||
Canonical SMILES |
CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O
|
||||
InChI |
1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19)
|
||||
InChIKey |
PUXBGTOOZJQSKH-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=2581"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 273.71 | Topological Polar Surface Area | 53.1 | |
XlogP | 4 | Complexity | 362 | ||
Heavy Atom Count | 19 | Rotatable Bond Count | 2 | ||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 2 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Carprofen 100 mg tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Water; Croscarmellose sodium; Povidone; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Putney; Vedco | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Vetoquinol | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | TruRx | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Carprofen 25 mg tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Water; Croscarmellose sodium; Povidone; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Putney; Vedco | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Vetoquinol | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | TruRx | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Carprofen 75 mg tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Water; Croscarmellose sodium; Povidone; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Putney; Vedco | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Vetoquinol | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | TruRx | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.